Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - yellow fever virus 17 d-204 strain - suspension for injection - 1000 - yellow fever vaccines

Malta - English - Medicines Authority

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - yellow fever, virus strain, d - powder and solvent for suspension for injection - yellow fever virus strain 17d 1000 iu - vaccines

Canada - English - Health Canada

sanofi pasteur limited - yellow fever vaccine - powder for solution - 109648pfu - yellow fever vaccine 109648pfu - vaccines

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - yellow fever virus strain 17d - powder and solvent for suspension for injection

Singapore - English - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - live attenuated yellow fever virus strain 17 d - injection - live attenuated yellow fever virus strain 17 d not less than 1000 iu

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi pasteur - yellow fever virus 17 d-204 strain - powder and solvent for suspension for injection in pre-filled syringe - 1000 international unit(s) - yellow fever vaccines; yellow fever, live attenuated

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

novartis vaccines and diagnostics ltd - yellow fever virus strain 17d - powder and solvent for suspension for injection

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sanofi pasteur europe s.a. - yellow fever virus (live, attenuated) - powder and solvent for suspension for injection - yellow fever virus - yellow fever, live attenuated

Israel - English - Ministry of Health

sanofi israel ltd - yellow fever virus strain 17d204 (substrain ab237) - powder and solvent for suspension for injection - yellow fever virus strain 17d204 (substrain ab237) - yellow fever, live attenuated - stamaril is indicated for active immunization against yellow fever in persons:• travelling to, passing through or living in an endemic area,• travelling to any country that requires an international certificate of vaccination for entry(which may or may not depend on the previous itinerary).• handling potentially infectious materials (e.g. laboratory personnel).see sections 4.2, 4.3 and 4.4 regarding the minimum age for vaccination of children under special circumstances and guidance for vaccination of other specific patient populations.in order to comply with vaccine regulations and to be officially recognized, yellow fever vaccines must be administered in an approved world health organization (who) vaccination centre and registered on an international certificate of vaccination. the validity period of thiscertificate is established according to international health regulations (ihr) recommendations, and starts 10 days after primary vaccination and immediately after re-vaccination (see section 4.2).

Malta - English - Medicines Authority

medical logistics ltd no 8, ivo muscat azzopardi street, st julians stj 1905, malta - yellow fever, virus strain, d - powder and solvent for suspension for injection - yellow fever virus strain 17d 1000/0.5 international unit(s)/millilitre - vaccines